Two Sigma Investments, LP Evelo Biosciences, Inc. Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.46 - $3.55 $113,602 - $276,225	-77,810 Reduced 74.87%	26,116 $55,000
Q1 2022 May 16, 2022	BUY	$2.66 - $6.63 $240,985 - $600,651	90,596 Added 679.64%	103,926 $352,000
Q4 2021 Feb 14, 2022	SELL	$6.07 - $12.0 $20,455 - $40,440	-3,370 Reduced 20.18%	13,330 $81,000
Q3 2021 Nov 15, 2021	SELL	$6.79 - $13.9 $453,531 - $928,436	-66,794 Reduced 80.0%	16,700 $118,000
Q2 2021 Aug 16, 2021	SELL	$9.43 - $16.6 $511,124 - $899,753	-54,202 Reduced 39.36%	83,494 $1.15 Million
Q1 2021 May 17, 2021	BUY	$9.71 - $18.6 $1.34 Million - $2.56 Million	137,696 New	137,696 $1.47 Million

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.